Vera Therapeutics, Inc. (VERA) Misses Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts VERA Hot Sheet
Price: $35.05 +4.32%
EPS Growth %: -27.8%
Financial Fact:
Total Net Revenues: 3.85M
Today's EPS Names:
ANAB, ANIX, MNY, More
EPS Growth %: -27.8%
Financial Fact:
Total Net Revenues: 3.85M
Today's EPS Names:
ANAB, ANIX, MNY, More
Join SI Premium – FREE
Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q2 EPS of ($0.62), $0.06 worse than the analyst estimate of ($0.56).
For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Corning (GLW) files for up to $2B offering of common shares
- GMR Solutions to reprice $2.9B term loan, pay down $200M in debt
- Northrop Grumman wins two U.S. defense contracts worth $38.7m
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
